chr21-14964724-ATTCT-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM4BS2
The NM_003489.4(NRIP1):βc.3465_3468delβ(p.Lys1155AsnfsTer15) variant causes a frameshift change. The variant allele was found at a frequency of 0.000113 in 1,539,272 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (β β ).
Frequency
Genomes: π 0.00012 ( 0 hom., cov: 32)
Exomes π: 0.00011 ( 0 hom. )
Consequence
NRIP1
NM_003489.4 frameshift
NM_003489.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.24
Genes affected
NRIP1 (HGNC:8001): (nuclear receptor interacting protein 1) Nuclear receptor interacting protein 1 (NRIP1) is a nuclear protein that specifically interacts with the hormone-dependent activation domain AF2 of nuclear receptors. Also known as RIP140, this protein modulates transcriptional activity of the estrogen receptor. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM4
Frameshift in the end of transcript resulting in stoplost. Downstream stopcodon found after 1297 codons.
BS2
High AC in GnomAd4 at 19 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NRIP1 | NM_003489.4 | c.3465_3468del | p.Lys1155AsnfsTer15 | frameshift_variant | 4/4 | ENST00000318948.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NRIP1 | ENST00000318948.7 | c.3465_3468del | p.Lys1155AsnfsTer15 | frameshift_variant | 4/4 | 2 | NM_003489.4 | P1 | |
NRIP1 | ENST00000400199.5 | c.3465_3468del | p.Lys1155AsnfsTer15 | frameshift_variant | 3/3 | 3 | P1 | ||
NRIP1 | ENST00000400202.5 | c.3465_3468del | p.Lys1155AsnfsTer15 | frameshift_variant | 3/3 | 5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152134Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
19
AN:
152134
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000855 AC: 16AN: 187230Hom.: 0 AF XY: 0.0000702 AC XY: 7AN XY: 99740
GnomAD3 exomes
AF:
AC:
16
AN:
187230
Hom.:
AF XY:
AC XY:
7
AN XY:
99740
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000112 AC: 155AN: 1387020Hom.: 0 AF XY: 0.000114 AC XY: 78AN XY: 684354
GnomAD4 exome
AF:
AC:
155
AN:
1387020
Hom.:
AF XY:
AC XY:
78
AN XY:
684354
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000125 AC: 19AN: 152252Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74448
GnomAD4 genome
AF:
AC:
19
AN:
152252
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
74448
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 08, 2024 | Variant summary: NRIP1 c.3465_3468delAGAA (p.Lys1155AsnfsX15) causes a frameshift which results in an extension of the protein, altering the last 4 amino acids in the native protein sequence and extending the protein by 10 amino acid. The molecular mechanism of disease attributed to NRIP1 is gain-of-function. The variant allele was found at a frequency of 0.00011 in 1539272 control chromosomes. To our knowledge, no occurrence of c.3465_3468delAGAA in individuals affected with Congenital Anomalies Of Kidney And Urinary Tract 3 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 1723300). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 24, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with NRIP1-related conditions. This variant is present in population databases (rs776126740, gnomAD 0.03%). This sequence change results in a frameshift in the NRIP1 gene (p.Lys1155Asnfs*15). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 4 amino acid(s) of the NRIP1 protein and extend the protein by 10 additional amino acid residues. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at